Literature DB >> 17620455

TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells.

Susumu Nakae1, Motoyasu Iikura, Hajime Suto, Hisaya Akiba, Dale T Umetsu, Rosemarie H Dekruyff, Hirohisa Saito, Stephen J Galli.   

Abstract

Members of the T-cell immunoglobulin- and mucin-domain-containing molecule (TIM) family have roles in T-cell-mediated immune responses. TIM-1 and TIM-2 are predominantly expressed on T helper type 2 (Th2) cells, whereas TIM-3 is preferentially expressed on Th1 and Th17 cells. We found that TIM-1 and TIM-3, but neither TIM-2 nor TIM-4, were constitutively expressed on mouse peritoneal mast cells and bone marrow-derived cultured mast cells (BMCMCs). After IgE + Ag stimulation, TIM-1 expression was down-regulated on BMCMCs, whereas TIM-3 expression was up-regulated. We also found that recombinant mouse TIM-4 (rmTIM-4), which is a ligand for TIM-1, as well as an anti-TIM-3 polyclonal Ab, can promote interleukin-4 (IL-4), IL-6, and IL-13 production without enhancing degranulation in BMCMCs stimulated with IgE + Ag. Moreover, the anti-TIM-3 Ab, but neither anti-TIM-1 Ab nor rmTIM-4, suppressed mast-cell apoptosis. These observations suggest that TIM-1 and TIM-3 may be able to influence T-cell-mediated immune responses in part through effects on mast cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620455      PMCID: PMC1988955          DOI: 10.1182/blood-2006-11-058800

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay.

Authors:  P B Hill; A J MacDonald; E M Thornton; G F Newlands; S J Galli; H R Miller
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

3.  Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17.

Authors:  Susumu Nakae; Yoichiro Iwakura; Hajime Suto; Stephen J Galli
Journal:  J Leukoc Biol       Date:  2007-02-16       Impact factor: 4.962

4.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

Authors:  F T Liu; J W Bohn; E L Ferry; H Yamamoto; C A Molinaro; L A Sherman; N R Klinman; D H Katz
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

Review 6.  Mast cells in the development of adaptive immune responses.

Authors:  Stephen J Galli; Susumu Nakae; Mindy Tsai
Journal:  Nat Immunol       Date:  2005-02       Impact factor: 25.606

7.  Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma.

Authors:  Jeffrey A Encinas; Edith M Janssen; David B Weiner; Sandra A Calarota; Daisy Nieto; Thomas Moll; Dennis J Carlo; Ronald B Moss
Journal:  J Allergy Clin Immunol       Date:  2005-10-03       Impact factor: 10.793

8.  Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

Authors:  Alberto Sánchez-Fueyo; Jane Tian; Dominic Picarella; Christoph Domenig; Xin Xiao Zheng; Catherine A Sabatos; Natasha Manlongat; Orissa Bender; Thomas Kamradt; Vijay K Kuchroo; José-Carlos Gutiérrez-Ramos; Anthony J Coyle; Terry B Strom
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

Review 9.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

Review 10.  The TIM gene family: emerging roles in immunity and disease.

Authors:  Vijay K Kuchroo; Dale T Umetsu; Rosemarie H DeKruyff; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

View more
  72 in total

Review 1.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

3.  TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

Authors:  Lee A Albacker; Piia Karisola; Ya-Jen Chang; Sarah E Umetsu; Meixia Zhou; Omid Akbari; Norimoto Kobayashi; Nicole Baumgarth; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 4.  TIM-1 and TIM-3 proteins in immune regulation.

Authors:  Ee Wern Su; Jean Y Lin; Lawrence P Kane
Journal:  Cytokine       Date:  2008-08-15       Impact factor: 3.861

5.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

6.  Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats.

Authors:  Dingtai Wei; Xiaoxing Xiong; Heng Zhao
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

Review 7.  TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2013-09-18       Impact factor: 2.490

8.  Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.

Authors:  Toshiro Niki; Shoko Tsutsui; Shigeru Hirose; Sachiko Aradono; Yasushi Sugimoto; Keisuke Takeshita; Nozomu Nishi; Mitsuomi Hirashima
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

9.  T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells.

Authors:  Rosemarie H DeKruyff; Xia Bu; Angela Ballesteros; César Santiago; Yee-Ling E Chim; Hyun-Hee Lee; Piia Karisola; Muriel Pichavant; Gerardo G Kaplan; Dale T Umetsu; Gordon J Freeman; José M Casasnovas
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

10.  TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

Authors:  Yoshinori Yamanishi; Jiro Kitaura; Kumi Izawa; Ayako Kaitani; Yukiko Komeno; Masaki Nakamura; Satoshi Yamazaki; Yutaka Enomoto; Toshihiko Oki; Hisaya Akiba; Takaya Abe; Tadasuke Komori; Yoshihiro Morikawa; Hiroshi Kiyonari; Toshiyuki Takai; Ko Okumura; Toshio Kitamura
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.